Loading Events

« All Events

  • This event has passed.

Introducing the Hospital Anxiety and Depression Scale (HADS) for Use in Clinical Research

February 11, 2016 @ 10:00 - 23:00 UTC+0

Please enjoy the archive of this webinar delivered on February 11, 2016.

/

Webinar Topic:

Introducing the Hospital Anxiety and Depression Scale (HADS) for Use in Clinical Research

Webinar Date/Time:

Thursday, February 11, 2016 at

  • 10:00 AM ET (NYC, USA)
  • 3:00 PM GMT (London, UK)
  • 4:00 PM CET (Paris, FR)

Webinar Duration:

1 Hour (60 Minutes)

Webinar Host:

Pat McGuire cropped

Patrick McGuire -

International Business Consultant, GL Education Group

Dr. Lesley Dibley -

Research Associate, King’s College, London

Ldibley

Lesley brings 14 years clinical experience, and 8 years of higher education experience to her current role as research associate at King’s College London.

Since 2008, Lesley has worked with her Professor on a program of research addressing quality of life issues in people with Inflammatory Bowel Disease (IBD). Her research  tends to focus on the more sensitive aspects of IBD, and she has worked on projects to identify the prevalence of bowel incontinence in IBD, and to develop specific Patient Reported Outcome Measures (PROMs) for assessing continence status and disease-reported distress in IBD. She is currently coordinating a large clinical trial to test a low-level intervention for IBD-related incontinence, and is leading on three further studies addressing issues of concern in IBD. Lesley has published widely in leading academic journals, and has presented at conferences in the UK, Europe, and America. She has experience of using HADS as a benchmark for newly-developed PROMs, and to determine similarities or differences between anxiety and depression, and distress.

Lesley received her PhD from Coventry University (UK) in 2015. Her thesis explored the experience of stigma in IBD, and whether it was linked to either incontinence, or the disease itself, or both. She continues to research stigma in IBD.

Catherine Acquadro, MD -

Scientific Research Advisor, Mapi Group & Mapi Research Trust

Dr. Catherine Acquadro

Webinar Description:

The Hospital Anxiety and Depression Scale (HADS) was originally developed by Zigmond and Snaith (1983) and is commonly used by doctors to determine the levels of anxiety and depression that a patient is experiencing. The HADS is the most widely used instrument in oncology settings, however, its accuracy as a screening tool for minor and major depression is unclear.

Methods: A comprehensive search of the literature was conducted in order to identify primary studies examining the sensitivity and specificity of the HADS-Depression (HADS-D) subscale, when compared to a ‘gold standard’ interview to obtain psychiatric diagnosis.

The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression. Zigmond and Snaith created this outcome measure specifically to avoid reliance on aspects of these conditions that are also common somatic symptoms of illness, for example fatigue and insomnia or hypersomnia. This, it was hoped, would create a tool for the detection of anxiety and depression in people with physical health problems. This is what this webinar's discussion will focus upon -- how it can be used directly in modern-day clinical research studies.


button_reserve

Register to Attend this Live Webinar for Free Now:

http://webinars.mapigroup.com/hads-author-webinar-2016